PR Newswire
NEW YORK
,
May 24, 2022
/PRNewswire/ — Rowley Law PLLC is investigating potential securities law violations by Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX) and its board of directors concerning the proposed acquisition of the company by Innoviva, Inc. (NASDAQ: INVA). Stockholders will receive
$2.20
for each share of Entasis Therapeutics Holdings stock that they hold. Innoviva currently owns approximately 60% of Entasis Therapeutics Holdings common stock. The transaction is valued at approximately
$113 million
and is expected to close in the third quarter of 2022.
If you are a stockholder of Entasis Therapeutics Holdings Inc. and are interested in obtaining additional information regarding this investigation, please visit us at:
/. You may also contact
Shane Rowley, Esq.
at Rowley Law PLLC, 50 Main Street Suite 1000,
White Plains, NY
10606, by email at
[email protected]
, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit
.
Attorney Advertising. Prior results do not guarantee a similar outcome.
View original content:
https://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-entasis-therapeutics-holdings-inc-301554441.html
SOURCE Rowley Law PLLC
